Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2.

Despite extensive characterization of the mu-opioid receptor (MOR), the biochemical properties of the isolated receptor remain unclear. In light of recent reports, we proposed that the monomeric form of MOR can activate G proteins and be subject to allosteric regulation. A mu-opioid receptor fused to yellow fluorescent protein (YMOR) was constructed and expressed in insect cells. YMOR binds ligands with high affinity, displays agonist-stimulated [(35)S]guanosine 5'-(gamma-thio)triphosphate binding to Galpha(i), and is allosterically regulated by coupled G(i) protein heterotrimer both in insect cell membranes and as purified protein reconstituted into a phospholipid bilayer in the form of high density lipoprotein particles. Single-particle imaging of fluorescently labeled receptor indicates that the reconstituted YMOR is monomeric. Moreover, single-molecule imaging of a Cy3-labeled agonist, [Lys(7), Cys(8)]dermorphin, illustrates a novel method for studying G protein-coupled receptor-ligand binding and suggests that one molecule of agonist binds per monomeric YMOR. Together these data support the notion that oligomerization of the mu-opioid receptor is not required for agonist and antagonist binding and that the monomeric receptor is the minimal functional unit in regard to G protein activation and strong allosteric regulation of agonist binding by G proteins.

[1]  T. Huber,et al.  Rapid incorporation of functional rhodopsin into nanoscale apolipoprotein bound bilayer (NABB) particles. , 2008, Journal of molecular biology.

[2]  A. Engel,et al.  Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.

[3]  J. Traynor,et al.  Comparison of the Relative Efficacy and Potency of μ-Opioid Agonists to Activate Gαi/o Proteins Containing a Pertussis Toxin-Insensitive Mutation , 2006, Journal of Pharmacology and Experimental Therapeutics.

[4]  J T Williams,et al.  Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Akil,et al.  Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor. , 1998, The Journal of pharmacology and experimental therapeutics.

[6]  W. Schaffner,et al.  A rapid, sensitive, and specific method for the determination of protein in dilute solution. , 1973, Analytical biochemistry.

[7]  H. Loh,et al.  Isolation and purification of morphine receptor by affinity chromatography. , 1985, Life sciences.

[8]  A. Milon,et al.  Green fluorescent protein as a reporter of human μ-opioid receptor overexpression and localization in the methylotrophic yeast Pichia pastoris , 2002 .

[9]  S. Sligar,et al.  Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins. , 2007, Biochemistry.

[10]  Krzysztof Palczewski,et al.  Efficient Coupling of Transducin to Monomeric Rhodopsin in a Phospholipid Bilayer* , 2008, Journal of Biological Chemistry.

[11]  Graeme Milligan,et al.  G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.

[12]  R. Stevens,et al.  GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function , 2007, Science.

[13]  H. Akil,et al.  Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. , 1996, The Journal of pharmacology and experimental therapeutics.

[14]  T. Costa,et al.  Guanine nucleotide-mediated inhibition of opioid agonist binding. Modulatory effects of ions and of receptor occupancy. , 1989, Biochemical pharmacology.

[15]  P. Prather,et al.  Interaction of Co-Expressed μ- and δ-Opioid Receptors in Transfected Rat Pituitary GH3 Cells , 2001 .

[16]  R. Schulz,et al.  Expression of μ-, δ- and κ-opioid receptors in baculovirus-infected insect cells , 1996 .

[17]  A. Milon,et al.  Expression and pharmacological characterization of the human μ‐opioid receptor in the methylotrophic yeast Pichia pastoris , 1996, FEBS letters.

[18]  T. S. Kobilka,et al.  Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. , 1992, The Journal of biological chemistry.

[19]  L. Devi,et al.  Oligomerization of opioid receptors. , 2002, Methods.

[20]  J. Meunier,et al.  Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at μ- and κ-opioid receptor sites in rabbit and guinea-pig cerebellum membranes , 1985 .

[21]  D. Oprian,et al.  Transducin Activation by Nanoscale Lipid Bilayers Containing One and Two Rhodopsins* , 2007, Journal of Biological Chemistry.

[22]  P. Garriga,et al.  Effect of dodecyl maltoside detergent on rhodopsin stability and function , 2003, Vision Research.

[23]  E. Barnard,et al.  Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  B. O'dowd,et al.  Oligomerization of opioid receptors: generation of novel signaling units. , 2002, Current opinion in pharmacology.

[25]  Xiaochun Sun,et al.  Opioid Receptor Homo- and Heterodimerization in Living Cells by Quantitative Bioluminescence Resonance Energy Transfer , 2005, Molecular Pharmacology.

[26]  Richard N. Zare,et al.  A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein , 2007, Proceedings of the National Academy of Sciences.

[27]  Alain Milon,et al.  Optimizing functional versus total expression of the human mu-opioid receptor in Pichia pastoris. , 2002, Protein expression and purification.

[28]  S. Salvadori,et al.  Synthesis and receptor binding analysis of dermorphin hepta-, hexa- and pentapeptide analogues. Evidence for one- and two-side binding models for the mu-opioid receptor. , 2009, International journal of peptide and protein research.

[29]  Lakshmi A. Devi,et al.  Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy , 2000, The Journal of Neuroscience.

[30]  B. O'dowd,et al.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.

[31]  S. Sligar,et al.  Functional reconstitution of Beta2-adrenergic receptors utilizing self-assembling Nanodisc technology. , 2006, BioTechniques.

[32]  F. Simonin,et al.  Characterization of delta, kappa, and mu human opioid receptors overexpressed in baculovirus-infected insect cells. , 1997, The Journal of biological chemistry.

[33]  L. Devi,et al.  Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.

[34]  Krzysztof Palczewski,et al.  Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes* , 2003, Journal of Biological Chemistry.

[35]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[36]  B. Monsarrat,et al.  Solubilization, purification, and mass spectrometry analysis of the human mu-opioid receptor expressed in Pichia pastoris. , 2005, Protein expression and purification.

[37]  A. Blume,et al.  Coupling of opiate receptors to adenylate cyclase: requirement for Na+ and GTP. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Ballou,et al.  The use of protocatechuate dioxygenase for maintaining anaerobic conditions in biochemical experiments. , 2000, Analytical biochemistry.

[39]  W. Watkins,et al.  Purification of opioid receptor in the presence of sodium ions. , 1992, Life sciences.

[40]  T. Kenakin Principles: receptor theory in pharmacology. , 2004, Trends in pharmacological sciences.

[41]  B. Cox,et al.  Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes. , 1988, Molecular pharmacology.

[42]  E. J. Simon,et al.  Purification of an active opioid-binding protein from bovine striatum. , 1985, The Journal of biological chemistry.

[43]  A. Engel,et al.  Functional and Structural Characterization of Rhodopsin Oligomers* , 2006, Journal of Biological Chemistry.

[44]  Mei Bai,et al.  Dimerization of G-protein-coupled receptors: roles in signal transduction. , 2004, Cellular signalling.